Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Seth P Lerner

Showing results (161-170 of 294) with videos related to

Pageof 30
Sort By:
European Urology|June 24, 2006
Discrepancy between clinical and pathologic stage: impact on prognosis after radical cystectomyShahrokh F Shariat, Ganesh S Palapattu, Pierre I Karakiewicz, et al.
International Journal of Radiation Oncology, Biology, Physics|March 30, 2016
Validating a Local Failure Risk Stratification for Use in Prospective Studies of Adjuvant Radiation Therapy for Bladder CancerBrian C Baumann, Jiwei He, Wei-Ting Hwang, et al.
Cancer|June 12, 2009
Quality of pathologic response and surgery correlate with survival for patients with completely resected bladder cancer after neoadjuvant chemotherapyGuru Sonpavde, Bryan H Goldman, V O Speights, et al.
The Journal of Urology|June 16, 2009
Residual pathological stage at radical cystectomy significantly impacts outcomes for initial T2N0 bladder cancerHendrik Isbarn, Pierre I Karakiewicz, Shahrokh F Shariat, et al.
Translational Oncology|March 5, 2019
Androgen Receptor mRNA Expression in Urothelial Carcinoma of the Bladder: A Retrospective Analysis of Two Independent CohortsDanijel Sikic, Ralph M Wirtz, Sven Wach, et al.
European Urology Focus|July 20, 2017
Prognostic Significance of Neutrophilic Infiltration in Benign Lymph Nodes in Patients with Muscle-invasive Bladder CancerSumanta K Pal, Anh Pham, Winston Vuong, et al.
BJU International|November 22, 2014
Significance of lymphovascular invasion in organ-confined, node-negative urothelial cancer of the bladder: data from the prospective p53-MVAC trialFriedrich-Carl von Rundstedt, Douglas A Mata, Susan Groshen, et al.
Iscience|March 5, 2024
Multiomics profiling of urothelial carcinoma <i>in situ</i> reveals CIS-specific gene signature and immune characteristicsMeenakshi Anurag, Trine Strandgaard, Sung Han Kim, et al.
BJU International|December 17, 2008
Assessing the minimum number of lymph nodes needed at radical cystectomy in patients with bladder cancerUmberto Capitanio, Nazareno Suardi, Shahrokh F Shariat, et al.
European Urology|December 27, 2024
The Financial Burden of Localized and Metastatic Bladder CancerPietro Scilipoti, Marco Moschini, Roger Li, et al.
Pageof 30

Showing results (161-170 of 294) with videos related to

Sort By:
Pageof 30
European Urology|June 24, 2006
Discrepancy between clinical and pathologic stage: impact on prognosis after radical cystectomyShahrokh F Shariat, Ganesh S Palapattu, Pierre I Karakiewicz, et al.
International Journal of Radiation Oncology, Biology, Physics|March 30, 2016
Validating a Local Failure Risk Stratification for Use in Prospective Studies of Adjuvant Radiation Therapy for Bladder CancerBrian C Baumann, Jiwei He, Wei-Ting Hwang, et al.
Cancer|June 12, 2009
Quality of pathologic response and surgery correlate with survival for patients with completely resected bladder cancer after neoadjuvant chemotherapyGuru Sonpavde, Bryan H Goldman, V O Speights, et al.
The Journal of Urology|June 16, 2009
Residual pathological stage at radical cystectomy significantly impacts outcomes for initial T2N0 bladder cancerHendrik Isbarn, Pierre I Karakiewicz, Shahrokh F Shariat, et al.
Translational Oncology|March 5, 2019
Androgen Receptor mRNA Expression in Urothelial Carcinoma of the Bladder: A Retrospective Analysis of Two Independent CohortsDanijel Sikic, Ralph M Wirtz, Sven Wach, et al.
European Urology Focus|July 20, 2017
Prognostic Significance of Neutrophilic Infiltration in Benign Lymph Nodes in Patients with Muscle-invasive Bladder CancerSumanta K Pal, Anh Pham, Winston Vuong, et al.
BJU International|November 22, 2014
Significance of lymphovascular invasion in organ-confined, node-negative urothelial cancer of the bladder: data from the prospective p53-MVAC trialFriedrich-Carl von Rundstedt, Douglas A Mata, Susan Groshen, et al.
Iscience|March 5, 2024
Multiomics profiling of urothelial carcinoma <i>in situ</i> reveals CIS-specific gene signature and immune characteristicsMeenakshi Anurag, Trine Strandgaard, Sung Han Kim, et al.
BJU International|December 17, 2008
Assessing the minimum number of lymph nodes needed at radical cystectomy in patients with bladder cancerUmberto Capitanio, Nazareno Suardi, Shahrokh F Shariat, et al.
European Urology|December 27, 2024
The Financial Burden of Localized and Metastatic Bladder CancerPietro Scilipoti, Marco Moschini, Roger Li, et al.
Pageof 30